| | This journal provides immediate access to some articles. Other Issues: previous | next | latest | archiveCommentaries CB2 cannabinoid receptors: new vistas K Mackie and R A Ross PMCID: PMC2219534 Commentary Good news for CB1 receptors: endogenous agonists are in the right place M Maccarrone PMCID: PMC2219528 Reviews Review Articles Cannabinoid receptors and the regulation of bone mass I Bab and A Zimmer PMCID: PMC2219540 CB2 receptors in reproduction M Maccarrone PMCID: PMC2219526 The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin R G Pertwee PMCID: PMC2219532 CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies Á Arévalo-Martín, D García-Ovejero, O Gómez, A Rubio-Araiz, B Navarro-Galve, C Guaza, E Molina-Holgado, and F Molina-Holgado PMCID: PMC2219542 Biology and therapeutic potential of cannabinoid CB2 receptor inverse agonists C A Lunn, E-P Reich, J S Fine, B Lavey, J A Kozlowski, R W Hipkin, D J Lundell, and L Bober PMCID: PMC2219522 CB2 receptors in the brain: role in central immune function G A Cabral, E S Raborn, L Griffin, J Dennis, and F Marciano-Cabral PMCID: PMC2219530 Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning P Pacher and G Haskó PMCID: PMC2219536 Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation K L Wright, M Duncan, and K A Sharkey PMCID: PMC2219529 Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor B N Dittel PMCID: PMC2219523 Cannabinoid CB2 receptors in human brain inflammation C Benito, R M Tolón, M R Pazos, E Núñez, A I Castillo, and J Romero PMCID: PMC2219537 CB2 receptors as new therapeutic targets for liver diseases S Lotersztajn, F Teixeira-Clerc, B Julien, V Deveaux, Y Ichigotani, S Manin, J Tran-Van-Nhieu, M Karsak, A Zimmer, and A Mallat PMCID: PMC2219531 Cannabinoid receptors in acute and chronic complications of atherosclerosis F Mach, F Montecucco, and S Steffens PMCID: PMC2219535 CB2 receptor-mediated migration of immune cells: it can go either way A M Miller and N Stella PMCID: PMC2219538 The peripheral cannabinoid receptor knockout mice: an update N E Buckley PMCID: PMC2219525 Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain J Guindon and A G Hohmann PMCID: PMC2219541 Targeting the cannabinoid CB2 receptor: modelling and structural determinants of CB2 selective ligands A Poso and J W Huffman PMCID: PMC2219524 Research Papers Cardiovascular and Pulmonary Pharmacology CB2 cannabinoid receptor agonists attenuate TNF-α-induced human vascular smooth muscle cell proliferation and migration M Rajesh, P Mukhopadhyay, G Haskó, J W Huffman, K Mackie, and P Pacher PMCID: PMC2219520 Immunopharmacology and Inflammation In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints J J McDougall, V Yu, and J Thomson PMCID: PMC2219539 Neuropharmacology Differential effects of cannabinoid receptor agonists on regional brain activity using pharmacological MRI C-L Chin, A E Tovcimak, V P Hradil, T R Seifert, P R Hollingsworth, P Chandran, C Z Zhu, D Gauvin, M Pai, J Wetter, G C Hsieh, P Honore, J M Frost, M J Dart, M D Meyer, B B Yao, B F Cox, and G B Fox PMCID: PMC2219521 Compartmentalization of endocannabinoids into lipid rafts in a dorsal root ganglion cell line N Rimmerman, H V Hughes, H B Bradshaw, M X Pazos, K Mackie, A L Prieto, and J M Walker PMCID: PMC2219527 In vitro and in vivo characterization of A-796260: a selective cannabinoid CB2 receptor agonist exhibiting analgesic activity in rodent pain models B B Yao, G C Hsieh, J M Frost, Y Fan, T R Garrison, A V Daza, G K Grayson, C Z Zhu, M Pai, P Chandran, A K Salyers, E J Wensink, P Honore, J P Sullivan, M J Dart, and M D Meyer PMCID: PMC2219533 |
